Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis

Oral Oncol. 2012 Apr;48(4):303-10. doi: 10.1016/j.oraloncology.2011.11.008. Epub 2011 Dec 3.

Abstract

Multiple genetic mutations with subsequent molecular events are required for progression of normal epithelial cells to cancer, with p53 mutations being a very common event in squamous carcinogenesis. Upregulation of nuclear factor kappa B (NF-κB) is an associated feature of malignancy, however studies have not examined purposeful overexpression of the NF-κB p65 subunit in in vitro models of oral carcinogenesis. Our objective is to demonstrate that NF-κB p65 transfection into p53 deficient Rhek keratinocytes produces carcinogenic progression. We constitutively over-expressed NF-κB p65 in Rhek keratinocytes, previously immortalized by SV 40 thus inactivating p53, and studied NF-κB dependent events. NF-κB p65 overexpression provided functional upregulation of NF-κB and produced cyclin D1-mediated proliferation and interleukin 8 transcription and secretion. Consequently, we demonstrated tumorigenesis in athymic mice with NF-κB p65 overexpressing cells. We conclude NF-κB p65 overexpression in p53 inactivated immortalized keratinocytes produces tumorigenesis, and that this single alteration in NF-κB expression on a p53 inactivated background is sufficient for squamous carcinogenesis features, thus providing evidence that p65 may act as a gain of function oncogene in this setting.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Squamous Cell / metabolism*
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic / metabolism*
  • Cyclin D1 / metabolism
  • Disease Models, Animal
  • Female
  • Humans
  • Interleukin-8 / metabolism
  • Keratinocytes / metabolism*
  • Mice
  • Mice, Nude
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Interleukin-8
  • NF-kappa B
  • Vascular Endothelial Growth Factor A
  • Cyclin D1